featured
Local Ablative Therapy for Patients With Oligometastatic Prostate Cancer Is Safe and Effective
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
European Urology Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Toxicity and Efficacy of Local Ablative, Image-guided Radiotherapy in Gallium-68 Prostate-specific Membrane Antigen Targeted Positron Emission Tomography-staged, Castration-sensitive Oligometastatic Prostate Cancer: The OLI-P Phase 2 Clinical Trial
Eur Urol Oncol 2021 Nov 13;[EPub Ahead of Print], T Hölscher, M Baumann, J Kotzerke, K Zöphel, F Paulsen, AC Müller, D Zips, L Koi, C Thomas, S Löck, M Krause, M Wirth, F LohausFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.